Arcus Share Price
NYSE: RCUS | Small Cap | HealthcareArcus Stock Performance
Arcus Share Price Today
As of 19 November 2026, Arcus Biosciences, Inc.'s share price is $15.78. The stock opened at $16.48, compared to its previous close of $16.41. During today's trading session, Arcus Biosciences, Inc.'s share price traded between $15.78 and $16.71, with an average price of $16.25. Over the past 52 weeks, the stock has recorded a high of $31.68 and a low of $15.78. In terms of performance, Arcus Biosciences, Inc.'s share price has declined by 37.86% over the last six months and is down 39.57% on a year-on-year basis.
Arcus Share Price Chart
Arcus Quarterly Profit & Loss
All figures in USD
Arcus Annual Profit & Loss
All figures in USD
Arcus Balance Sheet
All figures in USD Million
Arcus Cash Flow
All figures in USD Million
About Arcus
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
Arcus Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $18.40 | $15.78 | -13.28% |
Oct 2026 | $25.75 | $18.19 | -29.77% |
Sep 2026 | $29.41 | $25.90 | -15.36% |
Aug 2026 | $27.70 | $30.60 | +8.32% |
Jul 2026 | $30.91 | $28.25 | -8.32% |
Jun 2026 | $25.21 | $30.82 | +21.39% |
May 2026 | $25.41 | $25.39 | -0.53% |
Apr 2026 | $21.95 | $25.52 | +18.04% |
Mar 2026 | $20.39 | $21.62 | +6.03% |
Feb 2026 | $21.07 | $20.39 | -3.07% |
Jan 2026 | $23.55 | $21.04 | -11.73% |
Dec 2025 | $25.68 | $23.83 | -8.71% |